A detailed history of Hodges Capital Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Hodges Capital Management Inc. holds 35,602 shares of ABBV stock, worth $6.06 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
35,602
Previous 31,306 13.72%
Holding current value
$6.06 Million
Previous $5.7 Million 7.12%
% of portfolio
0.42%
Previous 0.36%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $664,977 - $776,544
4,296 Added 13.72%
35,602 $6.11 Million
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $1.4 Million - $1.59 Million
-8,742 Reduced 21.83%
31,306 $5.7 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $2.17 Million - $2.44 Million
15,746 Added 64.79%
40,048 $6.21 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $1.39 Million - $1.61 Million
-10,405 Reduced 29.98%
24,302 $3.62 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $863,965 - $1.08 Million
-6,520 Reduced 15.81%
34,707 $5.68 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $122,340 - $140,892
-846 Reduced 2.01%
41,227 $6.72 Million
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $864,160 - $1.04 Million
6,248 Added 17.44%
42,073 $6.8 Million
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $1.12 Million - $1.28 Million
-8,313 Reduced 18.83%
35,825 $4.81 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $576,627 - $733,082
-4,190 Reduced 8.67%
44,138 $6.76 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $1.31 Million - $1.62 Million
-9,915 Reduced 17.02%
48,328 $7.84 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $50,599 - $64,023
-471 Reduced 0.8%
58,243 $7.89 Million
Q3 2021

Oct 06, 2021

BUY
$106.4 - $120.78 $658,190 - $747,145
6,186 Added 11.78%
58,714 $6.33 Million
Q2 2021

Jul 06, 2021

SELL
$105.21 - $117.21 $845,783 - $942,251
-8,039 Reduced 13.27%
52,528 $5.92 Million
Q1 2021

Apr 07, 2021

SELL
$102.3 - $112.62 $29,053 - $31,984
-284 Reduced 0.47%
60,567 $6.56 Million
Q4 2020

Feb 01, 2021

SELL
$80.49 - $108.67 $169,189 - $228,424
-2,102 Reduced 3.34%
60,851 $6.52 Million
Q3 2020

Oct 15, 2020

BUY
$85.91 - $100.83 $506,611 - $594,594
5,897 Added 10.34%
62,953 $5.51 Million
Q2 2020

Jul 22, 2020

BUY
$73.37 - $98.18 $172,712 - $231,115
2,354 Added 4.3%
57,056 $5.6 Million
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $244,584 - $370,819
-3,792 Reduced 6.48%
54,702 $4.17 Million
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $1.14 Million - $1.43 Million
15,797 Added 37.0%
58,494 $5.24 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $562,474 - $676,255
8,931 Added 26.45%
42,697 $3.23 Million
Q2 2019

Aug 22, 2019

SELL
$65.7 - $83.98 $2.07 Million - $2.65 Million
-31,513 Closed
0 $0
Q1 2019

Apr 15, 2019

SELL
$77.14 - $90.79 $229,800 - $270,463
-2,979 Reduced 8.64%
31,513 $2.54 Million
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $601,391 - $741,677
-7,725 Reduced 18.3%
34,492 $3.18 Million
Q3 2018

Oct 29, 2018

BUY
$88.91 - $98.84 $42,410 - $47,146
477 Added 1.14%
42,217 $3.99 Million
Q2 2018

Jul 26, 2018

SELL
$89.78 - $106.23 $53,059 - $62,781
-591 Reduced 1.4%
41,740 $3.87 Million
Q1 2018

May 03, 2018

BUY
$92.01 - $123.21 $534,210 - $715,357
5,806 Added 15.9%
42,331 $4.01 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $265,903 - $291,585
-2,969 Reduced 7.52%
36,525 $3.53 Million
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $2.76 Million - $3.52 Million
39,494
39,494 $3.51 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hodges Capital Management Inc. Portfolio

Follow Hodges Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hodges Capital Management Inc. with notifications on news.